About CCP

Returning for it’s 6th year, the Commercializing Continuous Processing in Pharma Summit (CCP) is the only strategical continuous manufacturing meeting to unite both small and large molecule modalities, to pair technical case studies with the business-case-realities of technology innovation.  

Curated with industry leaders, this is the longest standing peer-led meeting encompassing all aspects in the integration of continuous processing in Pharma. After near-24 months apart, the community will unite to: 

  • Showcase pilot plant to commercial scale real-world case studies, providing an industry benchmark for you and your stakeholders  
  • Give you clarity and updates on the global regulatory landscape  
  • Equip you with the latest PAT technologies and how to conduct a seamless, validated tech transfer 
  • Explore how gene therapies, vaccines and non-traditional applications can increase their stake in the continuous industry 

Featuring 3 workshop sessions exploring the current state of play in continuous manufacturing, first steps to implement in your organization & how to expand your continuous processing capabilities across drug portfolios, a site visit to CONTINUUS pharmaceuticals, and a jammed-packed main agenda featuring cutting-edge presentations from leading pharma and biotech, CCP 2022 is our most comprehensive to date. You are guaranteed to walk away with actionable insights that you can use to drive value in your department and company-wide, to drive down manufacturing costs and increase product quality.

View the agenda at a glance for a birds-eye view of what’s on:

agenda at a glance